You are here

  • Home
  • Archive
  • Volume 70, Issue 5
  • A multicentre, randomised, double-blind, placebo-controlled trial with the interleukin-1 receptor antagonist anakinra in patients with systemic-onset juvenile idiopathic arthritis (ANAJIS trial)

Citation Tools

Article menu
Clinical and epidemiological research
Extended report
A multicentre, randomised, double-blind, placebo-controlled trial with the interleukin-1 receptor antagonist anakinra in patients with systemic-onset juvenile idiopathic arthritis (ANAJIS trial)

Download to a citation manager

Download the citation for this article by clicking on one of the following citation managers:

Cite this article as:
Quartier P, Allantaz F, Cimaz R, et al
A multicentre, randomised, double-blind, placebo-controlled trial with the interleukin-1 receptor antagonist anakinra in patients with systemic-onset juvenile idiopathic arthritis (ANAJIS trial)
Annals of the Rheumatic Diseases 2011;70:747-754.